Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Systemic Treatment for Adults with Synovial Sarcoma.

Desar IME, Fleuren EDG, van der Graaf WTA.

Curr Treat Options Oncol. 2018 Mar 7;19(2):13. doi: 10.1007/s11864-018-0525-1. Review.

3.

Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases.

Zanardi E, Maruzzo M, Montesco MC, Roma A, Rastrelli M, Basso U.

Anticancer Drugs. 2014 Nov;25(10):1227-30. doi: 10.1097/CAD.0000000000000158.

4.

Primary Pleural Synovial Sarcoma Treated with Pazopanib.

Sugitani A, Asai K, Kojima K, Eguchi Y, Kawaguchi T, Ohsawa M, Hirata K.

Intern Med. 2015;54(16):2051-5. doi: 10.2169/internalmedicine.54.3570. Epub 2015 Aug 15.

5.

Trabectedin clinical cases: use according to indication in diverse clinical scenarios.

Grignani G, Martín-Broto J, Schuler M, Reichardt P.

Future Oncol. 2015;11(11 Suppl):15-24. doi: 10.2217/fon.15.76.

PMID:
26043311
6.

Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.

Salah S, Yaser S, Salem A, Al Mousa A, Abu Sheikha A, Sultan I.

Med Oncol. 2013;30(3):639. doi: 10.1007/s12032-013-0639-z. Epub 2013 Jun 19.

PMID:
23780657
7.

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.

Spurrell EL, Fisher C, Thomas JM, Judson IR.

Ann Oncol. 2005 Mar;16(3):437-44. Epub 2005 Jan 14.

PMID:
15653701
8.

A case of renal synovial sarcoma treated with adjuvant ifosfamide and doxorubicin.

Ozkan EE, Mertsoylu H, Ozardali HI.

Intern Med. 2011;50(15):1575-80. Epub 2011 Aug 1. Review.

9.

A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.

Bokemeyer C, Franzke A, Hartmann JT, Schöber C, Arseniev L, Metzner B, Link H, Kanz L, Schmoll HJ.

Cancer. 1997 Oct 1;80(7):1221-7.

PMID:
9317171
10.

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.

Eilber FC, Brennan MF, Eilber FR, Eckardt JJ, Grobmyer SR, Riedel E, Forscher C, Maki RG, Singer S.

Ann Surg. 2007 Jul;246(1):105-13.

11.

Rebound thymic hyperplasia after pneumonectomy and chemotherapy for primary synovial sarcoma.

Ford ME, Stevens R, Rosado-de-Christenson ML, Hall NC, Suster S.

J Thorac Imaging. 2008 Aug;23(3):178-81. doi: 10.1097/RTI.0b013e3181620e61.

PMID:
18728544
12.

Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.

[No authors listed]

Drugs R D. 2006;7(5):317-28. Review.

PMID:
16922593
13.

[Combination effect of pirarubicin, ifosfamide, and vincristine sulfate in the treatment of advanced synovial sarcoma--report of a case].

Shinozaki T, Matsushita M, Kusawake H, Watanabe H, Arita S, Chigira M, Udagawa E.

Gan To Kagaku Ryoho. 1995 Sep;22(10):1389-91. Japanese.

PMID:
7668875
14.

Characterization and chemotherapy of human soft tissue sarcoma (STS) lines grown in nude mice.

Boven E, Calame JJ, Molthoff CF, Pinedo HM.

Strahlenther Onkol. 1989 Jul;165(7):538-9. No abstract available.

PMID:
2546270
15.

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.

Sharma S, Takyar S, Manson SC, Powell S, Penel N.

BMC Cancer. 2013 Aug 13;13:385. doi: 10.1186/1471-2407-13-385. Review.

16.

Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

Kim JH, Park HS, Heo SJ, Kim SK, Han JW, Shin KH, Kim SH, Hur H, Kim KS, Choi YD, Kim S, Lee YH, Suh JS, Ahn JB, Chung HC, Noh SH, Rha SY, Kim HS.

Oncology. 2019;96(2):59-69. doi: 10.1159/000492597. Epub 2018 Oct 18.

PMID:
30336470
17.

Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.

Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS.

Oncologist. 2017 Oct;22(10):1271-1277. doi: 10.1634/theoncologist.2016-0464. Epub 2017 Jul 14.

18.

Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience.

Fernberg JO, Wiklund T, Monge O, Hall KS, Saeter G, Alvegård TA, Strander H.

Acta Orthop Scand Suppl. 1999 Jun;285:62-8.

PMID:
10429625
19.

Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.

Kopp HG, Patel S, Brücher B, Hartmann JT.

Am J Clin Dermatol. 2008;9(4):207-17. Review.

PMID:
18572972
20.

A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide.

Park SJ, Kim HK, Kim CK, Park SK, Go ES, Kim ME, Hong DS.

Korean J Intern Med. 2004 Mar;19(1):62-5.

Supplemental Content

Support Center